Trial design of the MOTheR HDx study: a multicenter, open-label, prospective, randomized study to explore the morbidity and mortality in patients dialyzed with the Theranova HDx in comparison with online hemodiafiltration.

Patricia de SequeraRafael Pérez-GarcíaAlmudena VegaShaira Martínez-VaqueraJesús Guillermo AcostaKatia Pérez Del ValleMilagros Fernández-LucasMaría Antonia García-RubialesAntonio Luis García-HerreraElisabeth CollEvangelina MéridaPatricia Martínez-MiguelItziar CastañoBeatriz Gil-CasaresJulia GarroFrancisco Maduellnull null

Published in: Clinical kidney journal (2023)

The trial has already started.

Keyphrases

open label
phase iii
phase ii
study protocol
clinical trial
end stage renal disease
ejection fraction
newly diagnosed
randomized controlled trial
prognostic factors
squamous cell carcinoma
healthcare
social media
radiation therapy
placebo controlled